Results 221 to 230 of about 6,434,049 (298)

Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial. [PDF]

Eur Heart J
Yuan X, Ju F, Wu H, Zhao Y, Wang X, Liu S, Wang X, Zhu J, Su P, Xu F, Feng W, Yang Y, Wang Y, Sun H.   +13 more
europepmc   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Valvular Heart Disease Interventional Trials From 2000 to 2024: A Systematic Review. [PDF]

JACC Adv
Rivera FB, Tsai CM, Pine PLS, Tesoro N, Magalong JV, Bantayan NRB, Lin CJ, Tangco GA, Al-Abcha A, Singh M, Guerrero M.   +10 more
europepmc   +1 more source

Causal correlations between inflammatory proteins and heart failure: A two‐sample Mendelian randomization analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu, Gui‐Qin Liu, Ya‐Ping Peng, Li‐Ling Zhang, Xian‐Jin Wang, Liang‐Chuan Chen, Yuan‐Xi Zheng, Xue‐Jun Xiang, Rui Qiao, Xian‐He Lin   +9 more
wiley   +1 more source

Heightened propofol sensitivity and distinct electroencephalographic signatures in patients with valvular heart disease. [PDF]

BMC Anesthesiol
Mao Y, Shi Y, Zhu L, Wei Q, He Z, Song X, Dai X, He J, Zhang L, Gu E, Xu G, Jin Y.   +11 more
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

End-stage valvular heart disease requiring heart transplantation: risk profile, surgical modifiers, and myocardial pathology. [PDF]

BMC Cardiovasc Disord
Wang Y, Zhao Y, Wang W, Jia H, Chen X, Mo H, Sun Z, Wang X, Shu S, Shi H, Luo Z, Hua X, Cui H, Song J.   +13 more
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Valvular Heart Disease and Heart Failure in the Post-COVID-19 Era: A Narrative Review of Mechanisms, Diagnosis, Differential Assessment, and Clinical Outcomes. [PDF]

J Clin Med
Rada M, Petculescu IM, Pah AM, Avram A, Velimirovici DE, Velciov AB, Tudoran C, Iurciuc S, Utu D, Gheorghe DR, Craciun ML.   +10 more
europepmc   +1 more source